Research paper · 2025-08-03
OpenMed NER: Open-Source, Domain-Adapted State-of-the-Art Transformers for Biomedical NER Across 12 Public Datasets
Maziyar Panahi
Abstract
Named-entity recognition (NER) is fundamental to extracting structured information from the >80% of healthcare data that resides in unstructured clinical notes and biomedical literature. Despite recent advances with large language models, achieving state-of-the-art performance across diverse entity types while maintaining computational efficiency remains a significant challenge. We introduce OpenMed NER, a suite of open-source, domain-adapted transformer models that combine lightweight domain-adaptive pre-training (DAPT) with parameter-efficient Low-Rank Adaptation (LoRA). Our approach performs cost-effective DAPT on a 350k-passage corpus compiled from ethically sourced, publicly available research repositories and de-identified clinical notes (PubMed, arXiv, and MIMIC-III) using DeBERTa-v3, PubMedBERT, and BioELECTRA backbones. This is followed by task-specific fine-tuning with LoRA, which updates less than 1.5% of model parameters. We evaluate our models on 12 established biomedical NER benchmarks spanning chemicals, diseases, genes, and species. OpenMed NER achieves new state-of-the-art micro-F1 scores on 10 of these 12 datasets, with substantial gains across diverse entity types. Our models advance the state-of-the-art on foundational disease and chemical benchmarks (e.g., BC5CDR-Disease, +2.70 pp), while delivering even larger improvements of over 5.3 and 9.7 percentage points on more specialized gene and clinical cell line corpora. This work demonstrates that strategically adapted open-source models can surpass closed-source solutions. This performance is achieved with remarkable efficiency: training completes in under 12 hours on a single GPU with a low carbon footprint (< 1.2 kg CO2e), producing permissively licensed, open-source checkpoints designed to help practitioners facilitate compliance with emerging data protection and AI regulations, such as the EU AI Act.
Details
- arXiv identifier
- 2508.01630
- Published
- 2025-08-03
- Authors
- Maziyar Panahi
Models That Cite This Paper
- Described byOpenMed-NER-PharmaDetect-SuperClinical-434M
- Described byOpenMed-NER-ChemicalDetect-ModernMed-149M
- Described byOpenMed-NER-PharmaDetect-BigMed-278M
- Described byOpenMed-NER-BloodCancerDetect-TinyMed-65M
- Described byOpenMed-NER-DiseaseDetect-BioMed-335M
- Described byOpenMed-NER-OncologyDetect-MultiMed-568M
- Described byOpenMed-NER-AnatomyDetect-ElectraMed-109M
- Described byOpenMed-NER-ChemicalDetect-ModernMed-395M
- Described byOpenMed-NER-DNADetect-SuperMedical-125M
- Described byOpenMed-NER-PathologyDetect-TinyMed-135M
- Described byOpenMed-NER-SpeciesDetect-ElectraMed-109M
- Described byOpenMed-NER-OncologyDetect-BigMed-278M
- Described byOpenMed-NER-OrganismDetect-BioPatient-108M
- Described byOpenMed-NER-GenomicDetect-PubMed-109M
- Described byOpenMed-NER-OrganismDetect-TinyMed-82M
- Described byOpenMed-NER-GenomeDetect-ModernMed-149M
- Described byOpenMed-NER-GenomeDetect-ModernMed-395M
- Described byOpenMed-NER-GenomicDetect-BigMed-560M
- Described byOpenMed-NER-ProteinDetect-SuperClinical-141M
- Described byOpenMed-NER-ChemicalDetect-MultiMed-568M
- Described byOpenMed-NER-ChemicalDetect-BigMed-560M
- Described byOpenMed-NER-DiseaseDetect-ElectraMed-109M
- Described byOpenMed-NER-SpeciesDetect-ModernMed-149M
- Described byOpenMed-NER-PharmaDetect-ModernClinical-149M
- Described byOpenMed-NER-DiseaseDetect-SuperClinical-434M
- Described byOpenMed-NER-BloodCancerDetect-ElectraMed-560M
- Described byOpenMed-NER-OrganismDetect-BioMed-109M
- Described byOpenMed-NER-GenomicDetect-PubMed-335M
- Described byOpenMed-NER-SpeciesDetect-ModernClinical-395M